Soft writers: Gayco Pharmacy

We worked with pharmaceutical software company soft writers to go to georgia and create a couple lifestyle testimonials. Check it out.

Spotlight

Meissa Vaccines

Meissa Vaccines is a private biotech company focused on the advancement of vaccines for respiratory syncytial virus (RSV), the largest unmet respiratory medical need in pediatrics, and rhinovirus, the leading cause of infectious disease worldwide. The company is also developing vaccines for parainfluenza and human metapneumovirus. Meissa Vaccines was founded on proprietary technologies employing synthetic biologic and reverse genetics to create safer, more effective vaccines. The technology is exclusively licensed from Dr. Martin Moore's laboratory at Emory University. Dr. Moore, together with Dr. Roderick Tang, a leading developer of viral vaccines, co-founded Meissa.

OTHER VIDEOS

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now

Spotlight

Meissa Vaccines

Meissa Vaccines is a private biotech company focused on the advancement of vaccines for respiratory syncytial virus (RSV), the largest unmet respiratory medical need in pediatrics, and rhinovirus, the leading cause of infectious disease worldwide. The company is also developing vaccines for parainfluenza and human metapneumovirus. Meissa Vaccines was founded on proprietary technologies employing synthetic biologic and reverse genetics to create safer, more effective vaccines. The technology is exclusively licensed from Dr. Martin Moore's laboratory at Emory University. Dr. Moore, together with Dr. Roderick Tang, a leading developer of viral vaccines, co-founded Meissa.

Events